post-bg-557
calendary May 8, 2023

New side effect of valproic acid

At the beginning of April 2023, a letter was published on the website of Roszdravnadzor for healthcare professionals about new data on the safety of drugs with an international non-proprietary name (INN) - valproic acid. This letter is based on a notice from Sanofi Russia regarding a higher risk of developing neurodevelopmental disorders (NDPD), including autism spectrum disorders, in children whose fathers received valproic acid therapy before and at the time of conception.

Valproic acid preparations are used to treat epilepsy and to treat and prevent bipolar disorder in adults. Valproic acid is also used to treat epilepsy and prevent high fever seizures in children under 6 years of age.

The basis for signaling about a new side effect was the results of a retrospective observational study conducted in three Nordic countries, according to which the risk of developing NDPD in the valproic acid group ranged from 5.6 % to 6.3 % compared with a risk of 2.5 % - 3.6 % in the lamotrigine/levetiracetam combination group.

Back in May 2018, the European Commission approved some recommendations of the Pharmacovigilance Risk Assessment Committee. These included a preclinical epigenetic study and six post-marketing safety studies (PASS), including one to assess the association between paternal exposure to valproic acid and the risk of NDPD.

Sanofi Russia plans to make appropriate changes to the instructions for medical use, as well as the development of new educational materials to inform medical professionals and patients about the possible risk.

The State Register of Medicines (GRLS) contains 20 valproic acid products with valid registration certificates, more than half of which are manufactured in Russia. According to AlphaRM and the Pharmvestnik portal, drugs with the active ingredient valproic acid occupy more than 11 % of the market of all antiepileptic drugs on the Russian pharmaceutical market.

 
References:
  1. https://roszdravnadzor.gov.ru/i/upload/images/2023/4/5/1680697419.55377-1-1889514.pdf
  2. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=3c1af379-1f90-4a9a-bb03-e6c03622f977
  3. https://pharmvestnik.ru/content/news/Minzdrav-izmenil-perechen-osnovanii-dlya-vneseniya-izmenenii-v-regdose-lekarstv.html

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE